Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Vibramycin (doxycycline)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – May 2011

Vibramycin (doxycycline monohydrate) Oral Suspension
Vibramycin (doxycycline hyclate) Capsules
Vibramycin (doxycycline calcium oral suspension) Syrup
Vibra-Tabs (doxycycline hyclate)

 

Summary View

ADVERSE REACTIONS

  • Stevens Johnson Syndrome, Toxic Epidermal Necrolysis and Erythema

 

-
-